Loading clinical trials...
Loading clinical trials...
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (REPERFUSE)
Conditions
Interventions
Cangrelor
best medical management
Locations
13
France
CHU de Besançon
Besançon, France
Hôpital Pellegrin (CHU de Bordeaux)
Bordeaux, France
Hospices civils de Lyon, Hôpital Pierre Wertheimer
Bron, France
Hôpital Salengro (CHU Lille)
Lille, France
Hôpital Dupuytren (CHU Limoges)
Limoges, France
CHU La Timone
Marseille, France
Start Date
March 2, 2022
Primary Completion Date
March 1, 2030
Completion Date
September 1, 2030
Last Updated
March 2, 2026
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions